Lactiga accepted into the MaRS portfolio

Feb 28, 2020 | Awards & Announcements

Lactiga was accepted as a health venture into the startup portfolio of MaRS Discovery District, North America’s largest urban innovation hub occupying 1.5 million square feet in downtown Toronto.

In the News

November 9, 2021

Got milk COVID-19 antibodies?

https://www.thestar.com/business/mars/2021/06/09/got-milk-covid-19-antibodies.html?rf

In the News

November 9, 2021

Can antibodies from human breast milk help in the COVID-19 fight?

https://www.theglobeandmail.com/canada/article-can-antibodies-from-human-breast-milk-help-in-the-covid-19-fight/

Press Releases

November 1, 2021

Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment

Original Post PRINCETON, N.J.--(BUSINESS WIRE)--Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement ...

2023